Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myocardial Lipid”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT05427786
What this trial is testing

Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

Who this might be right for
No-Reflow PhenomenonCoronary Artery DiseasePercutaneous Coronary Intervention
Korea University Anam Hospital 458
Not applicableLooking for participantsNCT07476703
What this trial is testing

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Who this might be right for
Coronary Artery DiseaseArterial Stiffness, Blood PressureAORTIC VALVE DISEASES+9 more
Danderyd Hospital 1,400
Post-approval studies (Phase 4)Not Yet RecruitingNCT07508254
What this trial is testing

Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndromes (ACS)Hypercholesterolemia
Punjab Institute of Cardology 120
Post-approval studies (Phase 4)Study completedNCT00552747
What this trial is testing

Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease

Who this might be right for
Coronary Heart DiseaseHyperlipidemia
National Heart Institute, Mexico 76
Not applicableStudy completedNCT00536965
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 951
Large-scale testing (Phase 3)Not Yet RecruitingNCT07440381
What this trial is testing

TriPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

Who this might be right for
Acute Coronary SyndromesSecondary PreventionLipids
Heart Care Foundation 600
Testing effectiveness (Phase 2)Study completedNCT00981981
What this trial is testing

Effect of the Molecular Weight of Oat β-glucan on Its Ability to Lower Serum Cholesterol

Who this might be right for
Hypercholesterolemia
Glycemic Index Laboratories, Inc 367
Large-scale testing (Phase 3)Study completedNCT00080275
What this trial is testing

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Who this might be right for
Hypercholesterolemia
Kos Pharmaceuticals 600
Post-approval studies (Phase 4)UnknownNCT01773512
What this trial is testing

The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques

Who this might be right for
Coronary Artery Disease
General University Hospital, Prague 60
Not applicableUnknownNCT05117424
What this trial is testing

CArdioMetabolism and Atherosclerotic PlaqUe progreSsion

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus, Type 2Dyslipidemias+2 more
Ruijin Hospital 3,000
Not applicableStudy completedNCT03167996
What this trial is testing

Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology

Who this might be right for
Cardiovascular Risk FactorInsulin ResistancePreDiabetes+5 more
Stanford University 38
Not applicableLooking for participantsNCT07704918
What this trial is testing

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

Who this might be right for
Melanoma
University of Colorado, Denver 40
Not applicableLooking for participantsNCT06776419
What this trial is testing

The Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease

Who this might be right for
Fabry DiseaseCardiovascular Diseases
Caroline Michaela Kistorp 54
Post-approval studies (Phase 4)UnknownNCT02015988
What this trial is testing

Simvastatin and Fenofibrate vs Simvastatin Alone in Patients With Type 2 Diabetes Mellitus and Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeDiabetes Mellitus, Type 2Hypertriglyceridemia
Koval' O., MD 60
Not applicableEnded earlyNCT01268319
What this trial is testing

CANARY: Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow

Who this might be right for
Coronary AtherosclerosisMyocardial InfarctionCoronary Plaque Embolization
Infraredx 85
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Not applicableUnknownNCT06115213
What this trial is testing

The North Kynouria Project

Who this might be right for
Cardiovascular DiseasesHeart DiseasesCerebrovascular Disease+7 more
University Hospital, Ioannina 7,000
Large-scale testing (Phase 3)Study completedNCT03570697
What this trial is testing

Imaging of Coronary Plaques in Participants Treated With Evolocumab

Who this might be right for
Coronary Artery Disease (CAD)
Amgen 164
Not applicableStudy completedNCT02033694
What this trial is testing

The Lipid-Rich Plaque Study

Who this might be right for
Coronary Artery DiseaseAtherosclerosis
Infraredx 1,563
Large-scale testing (Phase 3)Study completedNCT00300456
What this trial is testing

Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Who this might be right for
DyslipidemiaCoronary Heart DiseaseMixed Dyslipidemia
Abbott 657
Next Page